Melatonin-primed ADMSCs elicit an efficacious therapeutic response in improving high-fat diet induced non-alcoholic fatty liver disease in C57BL/6J mice

Abstract Background Stem cells are widely used for therapy including treatment of liver damage. Adipose-derived mesenchymal stem cells (ADMSCs) administered to treat fatty liver are known to improve liver function but their use is restricted due to a poor success rate. This study investigates effica...

Descripció completa

Dades bibliogràfiques

Autors principals:	Aliasgar Hatimbhai Vohra, Kapil Kumar Upadhyay, Apeksha Suhas Joshi, Hitarthi Swetang Vyas, Jaymesh Thadani, Ranjitsinh Vijaysinh Devkar
Format:	Artigo
Idioma:	Inglês
Publicat:	SpringerOpen 2021-12-01
Col·lecció:	Egyptian Liver Journal
Matèries:	Melatonin Non-alcoholic fatty liver disease Stem cell therapy Adipose-derived mesenchymal stem cells NAFLD
Accés en línia:	https://doi.org/10.1186/s43066-021-00157-w
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!